Vectors and methods for immunization or therapeutic protocols
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 15, 2002
Grant Date -
N/A
app pub date -
May 20, 1998
filing date -
May 20, 1997
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention shows that DNA vaccine vectors can be improved by removal of CpG-N motifs and optional addition of CpG-S motifs. In addition, for high and long-lasting levels of expression, the optimized vector should include a promoter/enhancer that is not down-regulated by the cytokines induced by the immunostimulatory CpG motifs. Vectors and methods of use for immunostimulation are provided herein. The invention also provides improved gene therapy vectors by determining the CpG-N and CpG-S motifs present in the construct, removing stimulatory CpG (CpG-S) motifs and/or inserting neutralizing CpG (CpG-N) motifs, thereby producing a nucleic acid construct providing enhanced expression of the therapeutic polypeptide. Methods of use for such vectors are also included herein.
First Claim
Other Claims data not available
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
- 274 Citation Count
- A61K Class
- 98.96 % this patent is cited more than
- 23 Age